I et 52 ugers randomiseret, dobbeltblindt, placebokontrolleret klinisk forsøg fik 96 patienter mellem 5 og 31 år Elaprase 0, 5 mg/ kg hver uge (n=32) eller 0, 5 mg/ kg hver anden uge (n=32) eller placebo (n=32).
In a 52-week, randomized, double-blind, placebo-controlled clinical study, 96 patients between the ages of 5 and 31 years received Elaprase 0.5 mg/ kg every week (n=32) or 0.5 mg/ kg every other week (n=32), or placebo (n=32).